Via Furious Seasons mental health news blog:
"Lipid regulators are usually the top revenue producers in the US, so this is big news and tells you a whole lot about how successful the off-label marketing campaigns of makers of the atypical antipsychotics have been. U.S. sales of antipsychotics in 2004 amounted to $9.6 billion, marking 52 percent growth in four years. "-Dawdy
In the article, Furious Seasons author, Philip Dawdy says this:
"I can assure one and all that America didn't suddenly develop millions of more people with psychotic disorders. These drugs are being used for depression now and that's where I bet the sales boost came from. America is no longer "Prozac Nation." It's now "Atypical Nation." And that ain't good."
~
In my opinion, the broad use prescribing of antipsychotics for everything under the sun such as off-label insomnia, depression and anxiety is asking for trouble for the health of Americans considering diabetes is a black box warning on antipsychotics, and long-term use effects on bodies and brains have not been done.
If the FDA approves Seroquel XR for depression and anxiety America will be at a pharmaceutical crossroad that never should have been.
Subscribe to:
Post Comments (Atom)
Posts
2 comments:
ha! our posts are almost duplicates!
this is so damn f---ed up...god help us.
yes, this is a wake up call, America's main drug is an antipsychotic, blows my mind!
ppl NEED to know what permanent movements and metabolic syndrome is besides diabetes..not worth the risk is my opinion
Post a Comment